findmyKOL
Clinical trialNCT00814879CompletedInterventional

Pilot Study of a Raltegravir Based NRTI Sparing Regimen

SponsorYale UniversityEnrollment60AIDSAcquired Immune Deficiency SyndromeHIV InfectionsHuman Immunodeficiency Virus
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This pilot study will provide data on the safety and efficacy of the combination of Raltegravir (RAL) 400mg BID + Atazanavir (ATV) 300 mg BID in Antiretroviral (ARV)-experienced subjects that have a suppressed HIV viral load on a Ritonavir (RTV) boosted Protease Inhibitor (PI) based regimen who are then switched to a regimen of RAL 400mg BID +ATV 300mg BID.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Saint Raphael Healthcare System

    New Haven, Connecticut, United States

  • Yale University School of Medicine

    New Haven, Connecticut, United States

  • Waterbury Hospital

    Waterbury, Connecticut, United States

  • Va Ct Healthcare Systems

    West Haven, Connecticut, United States

  • Comprehensive Care Center, Inc (dba Community Aids Network)

    Sarasota, Florida, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2009
Primary completion
31 May 2013
Completion
30 Nov 2013
Last update posted
4 Feb 2016
Registered enrollment
60
Registry id
NCT00814879

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.